Laboratory Testing - what we need and what we don't?

被引:9
|
作者
Moeckel, Martin [1 ,2 ,3 ]
Mueller, Christian [4 ,5 ]
Lindner, Tobias [6 ,7 ]
Searle, Julia [7 ,8 ]
机构
[1] Campus Virchow Klinikums, Arbeitsbereichs Notfallmed Rettungsstellen Aufnah, Berlin, Germany
[2] Campus Virchow Klinikums, Chest Pain Units, Berlin, Germany
[3] Campus Charite Mitte, Berlin, Germany
[4] Charite, Zent Lab, Berlin, Germany
[5] Charite, Forsch Grp Arbeitsbereiches Notfallmed, Berlin, Germany
[6] Charite, Chirurg & Unfallchirurg Orthopadie Klin Notfall &, Berlin, Germany
[7] Charite, Arbeitsbereiches Notfallmed, Berlin, Germany
[8] Charite, Bereich Forsch, Berlin, Germany
关键词
EMERGENCY-DEPARTMENT; PROCALCITONIN; DIAGNOSIS; GUIDELINES; MANAGEMENT; OUTCOMES; SOCIETY; SEPSIS; IDENTIFICATION; DISORDERS;
D O I
10.1055/s-0041-109207
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laboratory parameters in emergency medicine can be divided into 3 categories. Urgent obligatory parameters are necessary for immediate therapeutic decisions and must be available within 60 minutes. For these, testing in the emergency department (ED) as point-of-care-testing (POCT) should be considered. The second category are obligatory parameters which require diagnostic/therapeutic consequences in the emergency department, but are not necessary for immediate life-saving actions. Due to international consensus of a 4-hour length of stay target for ED, results should be available within this time. The third category are parameters which do not lead to immediate diagnostic or therapeutic consequences, but are important for process management and patient flow in the ED. They should therefore be available as emergency tests. POC-testing should be used for a limited number of very urgent parameters and should be organized as a satellite laboratory in cooperation with the central laboratory.
引用
收藏
页码:322 / +
页数:9
相关论文
共 50 条
  • [31] Peri-implant disease: what we know and what we need to know
    Valente, Nicola Alberto
    Andreana, Sebastiano
    JOURNAL OF PERIODONTAL AND IMPLANT SCIENCE, 2016, 46 (03) : 136 - 151
  • [32] What we don't need to prove but need to do in multidisciplinary treatment and care in Huntington's disease: a position paper
    Alzbeta Mühlbӓck
    Marleen van Walsem
    Martha Nance
    Astri Arnesen
    Kirsty Page
    Alexandra Fisher
    Manon van Kampen
    Angela Nuzzi
    Roy Limpert
    Hanne Ludt Fossmo
    Travis Cruickshank
    Ruth Veenhuizen
    Orphanet Journal of Rare Diseases, 18
  • [33] Lung cancer biomarkers - Where we are and what we need
    Stieber, Petra
    Holdenrieder, Stefan
    CANCER BIOMARKERS, 2010, 6 (3-4) : 221 - 224
  • [34] Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
    Gershman, Boris
    Boorjian, Stephen A.
    Hautmann, Richard E.
    BLADDER CANCER, 2016, 2 (01) : 1 - 14
  • [35] COVID-19 Vaccination-Related Myocarditis: What We Learned From Our Experience and What We Need to Do in The Future
    Park, Jae-Hyeong
    Kim, Kye Hun
    KOREAN CIRCULATION JOURNAL, 2024, 54 (06) : 295 - 310
  • [36] Ultrasound of Skin Cancer: What We Need to Know
    Catalano, Orlando
    Corvino, Antonio
    SEMINARS IN ULTRASOUND CT AND MRI, 2024, 45 (03) : 216 - 232
  • [37] Food safety and cognitive biases: what we know, what we need to know, and why
    James, Harvey S.
    Segovia, Michelle
    Giwa-Daramola, Damilola
    BRITISH FOOD JOURNAL, 2023, 125 (10): : 3717 - 3733
  • [38] Guest editorial: Prejudice at work: what we understand and what we still need to learn
    Randolph, Angela
    Hinojosa, Amanda
    Randolph-Seng, Brandon
    MANAGEMENT DECISION, 2023, 61 (04) : 889 - 895
  • [39] Fluid resuscitation in diabetic ketoacidosis and the BPSED guidelines: what we still don't know
    Peters, Mark J.
    ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 2021, 106 (04): : 223 - 225
  • [40] Hypertension in the elderly: What we need to know
    Fernandez-Llama, P.
    Ayasreh, N.
    Calero, F.
    HIPERTENSION Y RIESGO VASCULAR, 2021, 38 (02): : 91 - 98